AstraZeneca’s coronavirus vaccine are due to production issues.The European Commission had asked the Belgian government to inspect the factory amid a heated public dispute between the 27-nation bloc and the Anglo-Swedish drugmaker.
EU officials are under tremendous political pressures because the bloc’s vaccine rollout has been much slower than that of Israel or Britain.The Novasep’s factory in the town of Seneffe is part of the European production chain for the Oxford-AstraZeneca coronavirus vaccine.AstraZeneca said last week that it planned to cut initial deliveries in the EU to 31 million doses from the 80 million it had planned due to reduced yields from its manufacturing plants in Europe.